AEterna Zentaris (TSX:AEZS) Other Operating Expense : C$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is AEterna Zentaris Other Operating Expense?

AEterna Zentaris's Other Operating Expense for the three months ended in Dec. 2023 was C$0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

AEterna Zentaris's quarterly Other Operating Expense increased from Jun. 2023 (C$0.00 Mil) to Sep. 2023 (C$0.00 Mil) but then stayed the same from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$0.00 Mil).

AEterna Zentaris's annual Other Operating Expense increased from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$0.00 Mil) but then declined from Dec. 2022 (C$0.00 Mil) to Dec. 2023 (C$0.00 Mil).

AEterna Zentaris Other Operating Expense Historical Data

The historical data trend for AEterna Zentaris's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris Other Operating Expense Chart

AEterna Zentaris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

AEterna Zentaris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

AEterna Zentaris Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

AEterna Zentaris Other Operating Expense Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

AEterna Zentaris (TSX:AEZS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (TSX:AEZS) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

AEZS:USA ET8:Germany

Address

222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.